301301SZSE

Verification Report on the Annual Storage, Management, and Use of Raised Funds by Tianjian Accounting Firm (Special General Partnership)

✨ AI Summary

This report verifies the annual storage, management, and use of raised funds by Yili Chuaning Biotechnology Co., Ltd. for 2025. The total amount raised was RMB 111.4 million, with a net amount of RMB 102.17 million after expenses. The funds were primarily used for project investments and working capital, with a remaining balance of RMB 6.43 million. The report concludes that the management's report complies with regulatory requirements.

Summary generated by AI · Always verify with source document

Full Translation

AI Translation· azure_openai

Verification Report on the Annual Storage, Management, and Use of Raised Funds

Tianjian Audit [2026] No. 8-124

To all shareholders of Yili Chuaning Biotechnology Co., Ltd.:

We have verified the "Special Report on the Annual Storage, Management, and Use of Raised Funds" for 2025 prepared by the management of Yili Chuaning Biotechnology Co., Ltd. (hereinafter referred to as Chuaning Biotechnology).

1. Limitation of Report Users and Purpose

This verification report is solely for the use of Chuaning Biotechnology during the disclosure of its annual report and shall not be used for any other purpose. We agree to include this verification report as a necessary document in Chuaning Biotechnology's annual report, submitted and disclosed externally along with other documents.

2. Management's Responsibility

The responsibility of Chuaning Biotechnology's management is to provide true, legal, and complete relevant materials, and to prepare the "Special Report on the Annual Storage, Management, and Use of Raised Funds" in accordance with the "Regulations on the Supervision of Raised Funds by Listed Companies" (CSRC Announcement [2025] No. 10) and the "Self-Regulatory Guidelines for Listed Companies on the Shenzhen Stock Exchange No. 2 - Standardized Operations of Growth Enterprise Market Listed Companies (2025 Revision)" (Shenzhen Stock Exchange [2025] No. 481), ensuring that its content is true, accurate, and complete, without false records, misleading statements, or significant omissions.

3. Responsibility of the Certified Public Accountant

Our responsibility is to independently provide a verification conclusion on the report prepared by the management of Chuaning Biotechnology based on the implementation of verification work.

4. Overview of Work

We performed the verification work in accordance with the Chinese Certified Public Accountant Practice Standards. These standards require us to plan and implement verification work to obtain reasonable assurance that there are no material misstatements in the information subject to verification. During the verification process, we implemented necessary procedures, including checking accounting records. We believe that our verification work provides a reasonable basis for our opinion.

5. Verification Conclusion

We believe that the "Special Report on the Annual Storage, Management, and Use of Raised Funds" for 2025 prepared by the management of Chuaning Biotechnology complies with the "Regulations on the Supervision of Raised Funds by Listed Companies" (CSRC Announcement [2025] No. 10) and the "Self-Regulatory Guidelines for Listed Companies on the Shenzhen Stock Exchange No. 2 - Standardized Operations of Growth Enterprise Market Listed Companies (2025 Revision)" (Shenzhen Stock Exchange [2025] No. 481), and accurately reflects the actual storage, management, and use of raised funds by Chuaning Biotechnology for the year 2025.

Tianjian Accounting Firm (Special General Partnership)

Certified Public Accountant: Hangzhou, China

Sign in to read the full translation

Free accounts get 10 full releases per month. Pro subscribers get unlimited access.